AFB-DNA (TB-PCR) Detection by Real Time PCR – CSF

The "AFB-DNA (TB-PCR) Detection by Real Time PCR – CSF" test is used to diagnose infection caused by Mycobacterium tuberculosis (MTB Complex) or Non-tuberculous mycobacteria (NTM or MOTT) in cerebrospinal fluid (CSF) samples. The initial AFB-DNA (TB-PCR) Detection by Real Time PCR identifies the presence of Mycobacterial DNA in the CSF sample, enabling healthcare professionals to detect MTB Complex or NTM/MOTT infections. If the result is MTB positive, the reflex test of Rifampicin resistance by Ultra CBNAAT is performed to determine if the MTB strain is resistant to Rifampicin, a critical drug used in TB treatment. This comprehensive diagnostic approach allows for rapid and accurate detection of Mycobacterial infections in CSF, facilitating prompt and appropriate treatment decisions. Early diagnosis through this test is essential for initiating timely and targeted therapy, preventing complications associated with these infections, and ensuring the best possible care for the patient's neurological health and overall well-being.